A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors

Clinical trial NCT04991506 · COMPLETED

Trial details

NCT number: NCT04991506
Sponsor: Elpiscience Biopharma, Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Neoplasms Malignant Tumor

Start date: 2021-10-15
Primary completion: 2024-05-17
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.